Previously, it was shown that CerK expression is higher in estrogen receptor (ER) negative than in ER positive breast cancer tissue, and that within the ER negative subgroup of patients, those with highest CerK expression had the worst prognosis and the shortest survival [21]. The gene discussed is CERK; the disease is breast carcinoma.